LEADER 01556nam 2200469 450 001 9910708101803321 005 20221105063518.0 035 $a(CKB)3450000000002422 035 $a(NjHacI)993450000000002422 035 $a(OCoLC)848778142 035 $a(EXLCZ)993450000000002422 100 $a20221105d2001 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aUses of epoetin for anemia in oncology /$fJ. Seidenfeld [and five others] 205 $aSummary ed. 210 1$aRockville, Maryland :$cAgency for Healthcare Research and Quality (US),$d[2001] 210 4$dİ2001 215 $a1 online resource 225 1 $aEvidence report/technology assessment,$x1530-440X ;$vno. 30 225 1 $aAHRQ publication ;$vno. 01-E 008 300 $aTitle from title screen (viewed Dec. 11, 2003). 300 $a"Current as of March 2001." 320 $aIncludes bibliographical references. 606 $aAnemia 606 $aAnemia$xDiagnosis 615 0$aAnemia. 615 0$aAnemia$xDiagnosis. 676 $a616.152 700 $aSeidenfeld$b J. 701 $aSeidenfeld$b Jerome$01417566 712 02$aBlue Cross and Blue Shield Association.$bTechnology Evaluation Center. 712 02$aUnited States.$bAgency for Healthcare Research and Quality. 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910708101803321 996 $aUses of epoetin for anemia in oncology$93526392 997 $aUNINA